remaining strong. Rotterdam PTA expansion required a tie-in shutdown lowering PTA production by 45KT. European market is displaying strength which continues in 3Q17 therefore the doubling of PTA output to
significantly in recent years. While it is our stated goal of doubling the EBITDA every five years, based on the LTM 3Q17 performance, we have achieved this target in four years itself. Note: Core EPS for 2013
growth has accelerat- ed significantly in recent years. While it is our stat- ed goal of doubling the EBITDA every five years, we have achieved this target in the last four years. IVL is well positioned to
growth has accelerat- ed significantly in recent years. While it is our stat- ed goal of doubling the EBITDA every five years, we have achieved this target in the last four years. IVL is well positioned to
No.1 position in functional drinks market for five consecutive quarters. C-Vitt showed 37.8% YoY in Q3’19 even with higher base (after doubling the capacity in Q2’18), while Peptein showed outstanding
to expand the business of take-home products (Take- home Products). Introduction of "After You Marketplace" Doubling the branch of “Mikka” coffee shop during 2021 3 Effective response to the New Normal
การตรวจสอบความถูกตองของ ขอมูลที่ไดรับวาเปนขอมูลชุดเดียวกับที่สงมาจากตนทางโดยปราศจากการทํ าซํ้ า (duplication) การแทรก ขอความ (insertion) การเปลี่ยนแปลง (modification) การสงซํ้ า (reordering